Inclusion and exclusion criteria for the MIlkMAN: pilot
| Criteria | Patient database searches | Screening interview |
| Inclusion | ||
| Aged 65 years and over | ||
| Live in the community | ||
| Exclusion | ||
| Diabetes mellitus type 1 or type 2 | Lacks capacity to consent to participate | |
| Chronic kidney disease stage 4 or 5 (estimated glomerular filtration rate<30 mL/min/1.73 m2) | Lactose intolerance | |
| Liver function impairment (AST>2.5 times upper limit of normal range within the last 6 months) | Dislikes milk or cranberry juice (control drink) | |
| Participated in a structured RE training and gym programme in the last month | ||
| Chronic lung disease requiring maintenance steroid therapy (eg, COPD, severe asthma) | Dislikes gym exercise with equipment | |
| End-stage terminal illness | Unintentional weight loss ≥5 kg in the last 3 months | |
| Cardiac pacemaker or severe heart failure or other significant heart disease | Unable to understand instructions for muscle strength and function assessments in English or unwilling to participate in protocol when explained | |
| Uncontrolled hypertension (>160/100 mm Hg) and uncontrolled hypotension (<100 mm Hg systolic) within last 6 months | An individual who the research team (exercise physiologist) evaluates as not suitable for the intervention because of safety reasons | |
| Hip or knee replacement | ||
| Impaired mobility (unable to walk without an aid including wheelchair) | ||
| Current prescription of warfarin (potential interference with control drink) | ||
| BMI≥30 kg/m2 | ||
| An individual who the GP feels it is inappropriate for the research team to approach for safety reasons: any medical and physical conditions that preclude safe participation in a RE programme (long-term conditions likely to lead impaired function over 6 months) | ||
AST, aspartate aminotransferase; BMI, body mass index; COPD, chronic obstructive pulmonary disease; GP, general practitioner.